Results 141 to 150 of about 199,181 (261)

Advances in FGF/FGFR Signaling: Implications for Disease and Therapy

MedComm, Volume 7, Issue 9, September 2026.
The FGF/FGFR signaling is indispensable for the maintenance of physiological homeostasis and governs multiple biological processes, including embryonic development, bone metabolism, angiogenesis, and neurogenesis, whereas aberrant hyperactivation of this pathway drives the progression of malignancies and autoimmune disorders, including inflammatory ...
Miaoyu Song, Xi Liu, Yang Xiao, Yongsheng Li, Huakan Zhao   +4 more
wiley   +1 more source

Urinary Dysfunction in Myasthenic Syndromes: A Scoping Review of Clinical Features and Treatment‐Related Associations

Muscle &Nerve, Volume 74, Issue S1, Page S97-S107, September 2026.
ABSTRACT Urinary dysfunction has been reported in association with myasthenic syndromes, including myasthenia gravis (MG), Lambert–Eaton myasthenic syndrome (LEMS), and congenital myasthenic syndromes (CMS), but evidence regarding its prevalence, clinical impact, pathophysiology, and management remains limited.
Julia M. Augustin, Lillith Horstkorte, Hellen Schmidt, Blanca G. Sánchez Navarro, Avan Kader, Inga Koneczny, Holly M. Nelson, Pratishtha P. Wadnerkar, Rafael Meleka Hanna, Ayşe N. Özdağ Acarlı, Piraye Oflazer, Atay Vural, Franz Blaes, Miriam L. Fichtner   +13 more
wiley   +1 more source

Improving the Patient Experience in Pediatric Cystometrography: A Prospective Observational Study

Neurourology and Urodynamics, Volume 45, Issue 7, Page 1304-1312, September 2026.
ABSTRACT Introduction Cystometrography, despite its invasive nature, is a crucial investigation for understanding and managing the bladder in children with neurogenic, non‐neurogenic and congenital bladder conditions. Results are influenced by child behaviors and artefacts, but results can be critical in developing patient‐specific management plans ...
Assia Comella, Amy Bodley, Hayley Nugara, Edwina Mcdonald, Neil Price, Elizabeth Dally, Chris Kimber, Kiarash Taghavi   +7 more
wiley   +1 more source

Urodynamic and Anamnestic Predictors for Individual Dose Adjustment of Intravesical Oxybutynin in Neurogenic Detrusor Overactivity: Results From the UPSIDE Study

Neurourology and Urodynamics, Volume 45, Issue 7, Page 1319-1327, September 2026.
ABSTRACT Introduction Intravesical oxybutynin (IVO) is a 2nd line treatment option for patients with neurogenic detrusor overactivity (NDO) who are not adequately managed by oral anticholinergics. The UPSIDE study aimed to identify urodynamic and anamnestic predictors for achieving a therapeutically satisfactory dose (TSD) of 1 mg/mL IVO and to ...
Arndt Van Ophoven, Severine Banek, Kristin Becker, Markus Heibel, Almut Hirsch, Margot Kieruj, Ines Kurze, Anja Lingnau, Barbara Ludwikowski, Tobias Luithle, Fabian Queissert, Wolfgang Rösch, Oliver Schindler, Regina Stredele, Thomas Michael Karl Völkl, Quentin Leidl, Michael Gedamke   +16 more
wiley   +1 more source

Morphologic and urodynamic predictors of renal scarring in pediatric neurogenic bladder A cross-sectional study. [PDF]

Can Urol Assoc J
Yayla D, Aydın Z.
europepmc   +1 more source

Unmasking pathogen traits for chronic colonization in neurogenic bladder. [PDF]

Cell Rep
Reasoner SA, Frainey BT, Hale OF, Borden A, Graham MK, Turner E, Brenes LR, Soderstrom CBW, Green H, Schmitz JE, Laub MT, Kelly MS, Clayton DB, Hadjifrangiskou M.   +13 more
europepmc   +1 more source

Prior Authorization for Sacral Nerve Stimulation in the Era of WISeR: Evaluation of U.S. Payer Coverage Policies

Neurourology and Urodynamics, Volume 45, Issue 7, Page 1280-1293, September 2026.
ABSTRACT Introduction Sacral nerve stimulation (SNS) is an established therapy for refractory urinary incontinence, yet the 2025 Wasteful and Inappropriate Service Reduction Model (WISeR) designated it as requiring mandatory prior authorization. No analysis has examined how U.S.
Thriaksh Rajan, Andre Revnew, David Sheyn, Adonis Hijaz, Ramy Abou Ghayda   +4 more
wiley   +1 more source

3D MR Fingerprinting for Quantitative Bladder Wall T1, T2, and M0 Mapping in Healthy Subjects at 1.5 T and 3 T

NMR in Biomedicine, Volume 39, Issue 9, September 2026.
Current diagnostic tests for lower urinary tract symptoms lack the ability to assess tissue‐level alterations in the bladder wall. This study introduces an approach for simultaneous high‐resolution 3D T1, T2, and proton density mapping of the bladder wall using magnetic resonance fingerprinting combined with a self‐supervised deep learning ...
Shane A. Wells, Giulia M. Ippolito, Melis Ozkan, Wilson Sui, Anne P. Cameron, Jesse I. Hamilton   +5 more
wiley   +1 more source

Efficacy of bilateral sacral neuromodulation in treating neurogenic bladder and bowel dysfunction. [PDF]

Transl Androl Urol
Li H, Li Y, Wang W, Zhang H, Hu Z, Zhang L, Cao Z, Yuan H, Fang H, Yan S, Liu Y, Xiao Y.   +11 more
europepmc   +1 more source

Independent Risk Factors for Postoperative Intestinal Obstruction and Clinical Outcomes in Simultaneous Pancreas‐Kidney Transplantation Recipients

Organ Medicine, Volume 3, Issue 3, Page 157-170, September 2026.
Intestinal obstruction (IO) is an important but underexplored complication following simultaneous pancreas‐kidney transplantation (SPKT) and is associated with considerable morbidity and both clinical and economic burdens. In this single‐center cohort study, perioperative parameters, including demographic characteristics, surgical variables, and ...
Rongxin Chen, Zebin Guo, Guanghui Li, Jiali Fang, Jialin Wu, Zhuangqiang Fang, Luhao Liu, Zheng Chen   +7 more
wiley   +1 more source